RECORD1 Study: REgulation of Coagulation in ORthopedic Surgery to prevent DVT and PE, controlled, double-blind, randomised study of BAY 59-7939 in the extended prevention of VTE in patients undergoing elective total hip replacement. - RECORD 1 Study
Phase 1
- Conditions
- Prevention of venous thromboembolism
- Registration Number
- EUCTR2005-004351-35-GR
- Lead Sponsor
- Bayer HealthCare AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Male and female patients aged 18 years or above.
Patients scheduled for elective total hip replacement.
Patients' written informed consent for participation after receiving detailed written and oral previous information to any study specific procedures.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method